CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
종목 코드 CBLL
회사 이름CeriBell Inc
상장일Oct 11, 2024
설립일2014
CEOMs. Xingjuan (Jane) Chao, Ph.D.
직원 수281
유형Ordinary Share
회계 연도 종료Oct 11
주소360 N. Pastoria Avenue
도시SUNNYVALE
증권 거래소NASDAQ Global Select Consolidated
국가United States of America
우편 번호94085
전화18004360826
웹사이트https://ceribell.com/
종목 코드 CBLL
상장일Oct 11, 2024
설립일2014
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음